GLP-1 Companion Nutrition: Keep the Muscle
If you're losing weight on a GLP-1 medication (semaglutide, tirzepatide), a meaningful share of that weight can be lean mass, more than typical dieting. This is a companion nutrition and training protocol, not medical advice about the drug itself: hit 25 to 30+ grams of protein at each meal, aiming toward the higher end of 1.2 to 2.0 g/kg/day while in a deficit, and do two full-body resistance sessions a week. Talk to your prescriber about your own medication plan; this page never doses the medication.
Understand why muscle protection matters more on a GLP-1
Why ↓
The larger total weight loss on a GLP-1, not some unique muscle-wasting effect of the drug, is why the absolute lean-mass loss is bigger and worth actively protecting against.
Anchor each meal at 25 to 30g+ protein
Why ↓
Adequate protein, split evenly across meals, is one of the two free, low-risk levers that helps protect lean mass during a deficit.
Two full-body resistance sessions a week
Why ↓
A 2025 systematic review and meta-analysis of 25 randomized trials found resistance training added to dieting produced a moderate-certainty protective effect on fat-free mass, with no reduction in fat loss; the included trials most often trained 2 to 3 times a week.
Talk to your prescriber about your own plan
Why ↓
Muscle protection is a companion strategy, not a substitute for medical supervision of the drug itself.
An exploratory DEXA sub-study of the STEP 1 trial (reported as a 2021 conference abstract, not a full peer-reviewed paper) found that roughly 39% of the weight semaglutide users lost was lean body mass (total weight -15.0% vs -3.6% placebo, total lean mass -9.7%); body-composition sub-studies of tirzepatide (SURMOUNT-1) show a comparable pattern.
Peter Attia, Lean mass loss on GLP-1 receptor agonists
Wilding JPH, Batterham RL, Calanna S, et al., Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study, Journal of the Endocrine Society 2021;5(Suppl 1):A16-A17
Body-composition sub-studies of tirzepatide (SURMOUNT-1), supporting context
Binmahfoz A, et al., Resistance training and fat-free mass during dieting: a systematic review and meta-analysis of 25 RCTs, BMJ Open Sport & Exercise Medicine 2025;11:e002363
Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Editorial disclosure. This protocol is written and fact-checked by the YourProtocol editorial team directly from the primary sources cited below; it is not written or reviewed by any outside expert.
Is this for you
- Anyone on a GLP-1 medication (or considering one) who wants to protect muscle while losing weight
- Anyone whose prescriber has already covered dosing and wants the nutrition and training side
- Readers who want the lean-mass claim's real evidentiary strength, not an inflated figure
Cautions
- Educational only, not medical advice; this page never doses the medication. Any decision to start, stop or adjust a GLP-1 belongs with your prescriber.
- The 39% lean-mass figure comes from an exploratory conference-abstract sub-study of STEP 1, not a full peer-reviewed paper; treat it as suggestive, not definitive.
- Losing some lean mass alongside fat during any weight loss is normal; the goal here is to minimize it, not eliminate it entirely.
- Talk to your prescriber before making significant changes to diet or exercise while on a GLP-1, especially with kidney disease or other conditions.